Improvement of Refractory Restless Legs Syndrome in a Parkinson’s Disease Patient After Semaglutide Treatment: A Novel Clinical Observation
Pasquale Maria Pecoraro, Silvia Lodico, Francesco Bugamelli, Martina Di Carluccio, Lazzaro di Biase · 2026
Read Improvement of Refractory Restless Legs Syndrome in a Parkinson’s Disease Patient After Semaglutide Treatment: A Novel Clinical Observation by Pasquale Maria Pecoraro, Silvia Lodico, Francesco Bugamelli, Martina Di Carluccio, Lazzaro di Biase (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13461288.txt.
Description
Pasquale Maria Pecoraro and colleagues wrote in 2026 a letter describing a 65-year-old man with Parkinson disease whose tormenting restless legs eased after he started semaglutide. His restless legs syndrome scored the maximum severity of forty on its rating scale, striking every evening for years. Standard options had failed him: gabapentin and pregabalin caused confusion and drowsiness without helping, and dopamine drugs were off the table after a past impulse-control problem.
Semaglutide, a diabetes drug of the GLP-1 family, has shown protective, anti-inflammatory effects in Parkinson research. Yet nobody had reported an effect on restless legs. The letter presents the timing as a possible causal association worth testing properly. It also lists his other conditions, from kidney disease to sleep apnea, that complicate any simple reading of one case.
Catalog record
| CREATOR | Pasquale Maria Pecoraro, Silvia Lodico, Francesco Bugamelli, Martina Di Carluccio, Lazzaro di Biase |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10018 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |